The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Major-Histocompatibility-Complex Class I Alleles and Antigens in Hematopoietic-Cell Transplantation
Open accessAbstract
BACKGROUND: Successful engraftment of hematopoietic stem cells from unrelated donors is influenced by disparities between the donor and recipient for HLA-A, B, and C alleles. Disparities between HLA sequence polymorphisms that are serologically detectable are termed antigen mismatches, whereas those that can be identified only by DNA-based typing methods are termed allele mismatches. Whether both kinds of polymorphisms are important in transplantation is not known. We tested the hypothesis that allele mismatches that are detectable only at the DNA level are less immunogenic than those that are serologically detectable and thereby are associated with a lower risk of graft failure after hematopoietic-cell transplantation METHODS: We used DNA sequencing to define the HLA-A, B, and C alleles in 471 patients who received bone marrow from unrelated donors for the treatment of chronic myeloid leukemia after myeloablative conditioning therapy. The odds ratios for graft failure were determined for recipients of transplants from donors with a single class I allele mismatch, a single class I antigen mismatch, or two or more class I mismatches, as compared with those with no mismatch RESULTS: A single HLA allele mismatch did not increase the risk of graft failure, whereas a single antigen mismatch significantly increased the risk. The risk was also increased if the recipient was HLA homozygous at the mismatched class I locus or if the donor had two or more class I mismatches CONCLUSIONS: HLA class I antigen mismatches that are serologically detectable confer an enhanced risk of graft failure after hematopoietic-cell transplantation. Transplants from donors with a single class I allele mismatch that is not serologically detectable may be used without an increased risk of graft failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Structure of the human class I histocompatibility antigen, HLA-A2
Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L., & Wiley, D. C. (1987) · Nature · doi:10.1038/329506a0 · Cited by 3,472
Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L., & Wiley, D. C. (1987) · Nature · doi:10.1038/329512a0 · Cited by 2,377
Structure of the complex between human T-cell receptor, viral peptide and HLA-A2
Garboczi, D. N., Ghosh, P., Utz, U., Fan, Q. R., Biddison, W. E., & Wiley, D. C. (1996) · Nature · doi:10.1038/384134a0 · Cited by 1,424
Klein, J., & Sato, A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009073431006 · Cited by 906
Nomenclature for Factors of the HLA System, 2004
Marsh, S. G. E., Albert, E. D., Bodmer, W. F., Bontrop, R. E., Dupont, B., Erlich, H. A., Geraghty, D. E., Hansen, J. A., Hurley, C. K., Mach, B., et al. (2005) · Human Immunology · doi:10.1016/j.humimm.2005.02.002 · Cited by 818
Self-citationPeptides Naturally Presented by MHC Class I Molecules
Rammensee, H. G., Falk, K., & Rötzschke, O. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001241 · Cited by 799
Anasetti, C., Amos, D., Beatty, P. G., Appelbaum, F. R., Bensinger, W., Buckner, C. D., Clift, R., Doney, K., Martin, P. J., Mickelson, E., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198901263200401 · Cited by 674
Self-citationPopulation Biology of Antigen Presentation by MHC Class I Molecules
Parham, P., & Ohta, T. (1996) · Science · doi:10.1126/science.272.5258.67 · Cited by 655
Bone Marrow Transplants from Unrelated Donors for Patients with Chronic Myeloid Leukemia
Hansen, J. A., Gooley, T. A., Martin, P. J., Appelbaum, F., Chauncey, T. R., Clift, R. A., Petersdorf, E. W., Radich, J., Sanders, J. E., Storb, R. F., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804023381405 · Cited by 570
Self-citationPetersdorf, E. W., Gooley, T. A., Anasetti, C., Martin, P. J., Smith, A. G., Mickelson, E. M., Woolfrey, A. E., & Hansen, J. A. (1998) · Blood · doi:10.1182/blood.v92.10.3515 · Cited by 480
Self-citationBONE MARROW TRANSPLANTS FROM UNRELATED DONORS FOR PATIENTS WITH CHRONIC MYELOID LEUKEMIA
Ansen, J. O. A. H., Ooley, A. G., Artin, P. A. J. M., et al. (1998) · Cited by 400
Structure of Peptides Associated with Class I and Class II MHC Molecules
Engelhard, V. H. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.181 · Cited by 395
The Origins of HLA‐A,B,C Polymorphism
Parham, P., Adams, E. J., & Arnett, K. L. (1995) · Immunological Reviews · doi:10.1111/j.1600-065x.1995.tb00674.x · Cited by 264
MARROW TRANSPLANTATION FROM HLA-MATCHED UNRELATED DONORS FOR TREATMENT OF HEMATOLOGIC MALIGNANCIES
BEATTY, P. G., HANSEN, J. A., LONGTON, G. M., THOMAS, E. D., SANDERS, J. E., MARTIN, P. J., BEARMAN, S. I., ANASETTI, C., PETERSDORF, E. W., MICKELSON, E. M., et al. (1991) · Transplantation · doi:10.1097/00007890-199102000-00034 · Cited by 251
Self-citationTwelve Years' Experience with National Sharing of HLA-Matched Cadaveric Kidneys for Transplantation
Takemoto, S. K., Terasaki, P. I., Gjertson, D. W., & Cecka, J. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010123431504 · Cited by 248
McGlave, P. B., Shu, X. O., Wen, W., Anasetti, C., Nademanee, A., Champlin, R., Antin, J. H., Kernan, N. A., King, R., & Weisdorf, D. J. (2000) · Blood · doi:10.1182/blood.v95.7.2219 · Cited by 235
Self-citationDavies, S. M., Kollman, C., Anasetti, C., Antin, J. H., Gajewski, J., Casper, J. T., Nademanee, A., Noreen, H., King, R., Confer, D., et al. (2000) · Blood · doi:10.1182/blood.v96.13.4096 · Cited by 215
Self-citationThe biological significance of HLA‐DP gene variation in haematopoietic cell transplantation
Petersdorf, E. W., Gooley, T., Malkki, M., Anasetti, C., Martin, P. J., Woolfrey, A. E., Smith, A. G., Mickelson, E., & Hansen, J. A. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02655.x · Cited by 159
Self-citationNeisig, A., Melief, C. J. M., & Neefjes, J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.171 · Cited by 121
Natural killer cells, HLA class I molecules, and marrow transplantation.
Valiante, N. M., & Parham, P. R. (1997) · PubMed · Cited by 34
Cited by
Barker, D. J., Maccari, G., Georgiou, X., Cooper, M. A., Flicek, P., Robinson, J., & Marsh, S. G. E. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkac1011 · Cited by 1,497
Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors
Anasetti, C., Logan, B. R., Lee, S. J., Waller, E. K., Weisdorf, D. J., Wingard, J. R., Cutler, C. S., Westervelt, P., Woolfrey, A., Couban, S., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203517 · Cited by 920
Self-citationCooley, S., Weisdorf, D. J., Guethlein, L. A., Klein, J. P., Wang, T., Le, C. T., Marsh, S. G. E., Geraghty, D., Spellman, S., Haagenson, M. D., et al. (2010) · Blood · doi:10.1182/blood-2010-05-283051 · Cited by 591
Taylor, C. J., Bolton, E. M., Pocock, S., Sharples, L. D., Pedersen, R. A., & Bradley, J. A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67813-0 · Cited by 493
Metadata
- Authors
- Petersdorf, E. W., Hansen, J. A., Martin, P. J., Woolfrey, A., Malkki, M., Gooley, T., Storer, B., Mickelson, E., Smith, A., & Anasetti, C.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2001-12-20
- Volume
- 345
- Issue
- 25
- Pages
- 1794-1800
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2083152756
- Cited by
- 335
- References
- 22
- FWCI
- 10.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.